Samuel Barker
Director/Board Member at LEXICON PHARMACEUTICALS, INC.
Net worth: 141 627 $ as of 30/04/2024
Samuel Barker active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2012 | - |
| Independent Dir/Board Member | 01/01/2012 | - | |
| Chairman | 01/01/2005 | 01/01/2012 | |
| CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 11/09/2014 | - |
| Independent Dir/Board Member | 11/09/2014 | - | |
The Cancer Institute of New Jersey
 The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Director/Board Member | - | - |
| Canvas Energy LLC | Director/Board Member | - | - |
Career history of Samuel Barker
Former positions of Samuel Barker
| Companies | Position | Start | End |
|---|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 01/08/2006 | 19/03/2014 |
| Independent Dir/Board Member | 01/08/2006 | 19/03/2014 | |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Director/Board Member | 01/01/2005 | 01/04/2009 |
| Clearview Projects, Inc. | Chief Executive Officer | 01/01/2003 | 01/01/2004 |
| Founder | 01/01/2001 | 01/01/2004 | |
| President | 01/01/2003 | 01/01/2004 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | 01/01/1999 |
United States Pharmaceutical Group LLC
 United States Pharmaceutical Group LLC Miscellaneous Commercial ServicesCommercial Services United States Pharmaceutical Group LLC provides healthcare support services. Its solutions include member enrollment, service and administration, comprehensive medical care services platform, benefit administration and offshore technical compliance (OTC) solutions, and employer group waiver plan. The company was founded on May 7, 2003 and is headquartered in Fort Lauderdale, FL. | President | 01/01/1992 | 01/01/1998 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Samuel Barker
| Henderson State University (Arkansas) | Undergraduate Degree |
| The University of Arkansas | Graduate Degree |
| Purdue University | Doctorate Degree |
Statistics
International
| United States | 14 |
Operational
| Director/Board Member | 6 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Health Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
United States Pharmaceutical Group LLC
United States Pharmaceutical Group LLC Miscellaneous Commercial ServicesCommercial Services United States Pharmaceutical Group LLC provides healthcare support services. Its solutions include member enrollment, service and administration, comprehensive medical care services platform, benefit administration and offshore technical compliance (OTC) solutions, and employer group waiver plan. The company was founded on May 7, 2003 and is headquartered in Fort Lauderdale, FL. | Commercial Services |
| Clearview Projects, Inc. | |
| Worldwide Franchise Systems, Inc. | |
| Canvas Energy LLC |
- Stock Market
- Insiders
- Samuel Barker
- Experience
